These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 22758607)

  • 1. Histamine H3 receptor antagonists in relation to epilepsy and neurodegeneration: a systemic consideration of recent progress and perspectives.
    Bhowmik M; Khanam R; Vohora D
    Br J Pharmacol; 2012 Dec; 167(7):1398-414. PubMed ID: 22758607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticonvulsant and procognitive properties of the non-imidazole histamine H3 receptor antagonist DL77 in male adult rats.
    Sadek B; Saad A; Subramanian D; Shafiullah M; Łażewska D; Kieć-Kononowiczc K
    Neuropharmacology; 2016 Jul; 106():46-55. PubMed ID: 26525191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-imidazole-based histamine H3 receptor antagonists with anticonvulsant activity in different seizure models in male adult rats.
    Sadek B; Saad A; Latacz G; Kuder K; Olejarz A; Karcz T; Stark H; Kieć-Kononowicz K
    Drug Des Devel Ther; 2016; 10():3879-3898. PubMed ID: 27932863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histamine H
    Ghamari N; Zarei O; Arias-Montaño JA; Reiner D; Dastmalchi S; Stark H; Hamzeh-Mivehroud M
    Pharmacol Ther; 2019 Aug; 200():69-84. PubMed ID: 31028835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histamine H3-receptor inverse agonists as novel antipsychotics.
    Ito C
    Cent Nerv Syst Agents Med Chem; 2009 Jun; 9(2):132-6. PubMed ID: 20021346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histamine H3 receptor antagonists go to clinics.
    Sander K; Kottke T; Stark H
    Biol Pharm Bull; 2008 Dec; 31(12):2163-81. PubMed ID: 19043195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on Anticonvulsant Effects of Novel Histamine H3R Antagonists in Electrically and Chemically Induced Seizures in Rats.
    Alachkar A; Łażewska D; Latacz G; Frank A; Siwek A; Lubelska A; Honkisz-Orzechowska E; Handzlik J; Stark H; Kieć-Kononowicz K; Sadek B
    Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30380674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in the development of histamine H
    Łażewska D; Kieć-Kononowicz K
    Expert Opin Ther Pat; 2018 Mar; 28(3):175-196. PubMed ID: 29334795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The histamine H3 receptor as a novel therapeutic target for cognitive and sleep disorders.
    Passani MB; Lin JS; Hancock A; Crochet S; Blandina P
    Trends Pharmacol Sci; 2004 Dec; 25(12):618-25. PubMed ID: 15530639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QSAR Modeling of Histamine H3R Antagonists/inverse Agonists as Future Drugs for Neurodegenerative Diseases.
    Correa MF; Dos Santos Fernandes JP
    Curr Neuropharmacol; 2018; 16(6):749-757. PubMed ID: 28820054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histamine H3 receptor antagonism by ABT-239 attenuates kainic acid induced excitotoxicity in mice.
    Bhowmik M; Saini N; Vohora D
    Brain Res; 2014 Sep; 1581():129-40. PubMed ID: 24952295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histamine H3 receptor function and ligands: recent developments.
    Singh M; Jadhav HR
    Mini Rev Med Chem; 2013 Jan; 13(1):47-57. PubMed ID: 22931528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The histamine H3 receptor: an attractive target for the treatment of cognitive disorders.
    Esbenshade TA; Browman KE; Bitner RS; Strakhova M; Cowart MD; Brioni JD
    Br J Pharmacol; 2008 Jul; 154(6):1166-81. PubMed ID: 18469850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-receptor kinetics and sigma-1 receptor affinity differentiate clinically evaluated histamine H
    Riddy DM; Cook AE; Shackleford DM; Pierce TL; Mocaer E; Mannoury la Cour C; Sors A; Charman WN; Summers RJ; Sexton PM; Christopoulos A; Langmead CJ
    Neuropharmacology; 2019 Jan; 144():244-255. PubMed ID: 30359639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evolution of histamine H₃ antagonists/inverse agonists.
    Lebois EP; Jones CK; Lindsley CW
    Curr Top Med Chem; 2011; 11(6):648-60. PubMed ID: 21261594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histamine H(3) receptor (H(3)R) antagonists and inverse agonists in the treatment of sleep disorders.
    Broderick M; Masri T
    Curr Pharm Des; 2011; 17(15):1426-9. PubMed ID: 21476958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the Histamine H
    Schlicker E; Kathmann M
    Handb Exp Pharmacol; 2017; 241():277-299. PubMed ID: 27787717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histamine H3 antagonists for treatment of cognitive deficits in CNS diseases.
    Raddatz R; Tao M; Hudkins RL
    Curr Top Med Chem; 2010; 10(2):153-69. PubMed ID: 20166960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in histamine H3 receptor antagonists/inverse agonists.
    Łazewska D; Kieć-Kononowicz K
    Expert Opin Ther Pat; 2010 Sep; 20(9):1147-69. PubMed ID: 20716022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of histaminergic receptor mechanisms in the stimulation of NT-3 synthesis in astrocytes.
    Jurič DM; Mele T; Carman-Kržan M
    Neuropharmacology; 2011 Jun; 60(7-8):1309-17. PubMed ID: 21276809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.